# ANASCORP

NDC: 66621-0150
Generic name: centruroides (scorpion) immune F(ab)2 (equine)
Labeler / Manufacturer: Rare Disease Therapeutics, Inc
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20110803

FDA application: BLA125335

## Active ingredients

- CENTRUROIDES FAB2 ANTIVENIN (EQUINE): 7 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66621-0150"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66621-0150